For Medical Professionals

Industry News

Why long time consumption of soyfoods reduces breast cancer recurrence
4/19/2015

Women diagnosed with breast cancer are often told not to eat soyfoods or soy-based supplements because they can interfere with anti-estrogen treatment.

Ovarian cancer: Genetic testing should be accessible to all women with the disease
4/18/2015

The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers.

New '4-D' lung cancer model could quicken discoveries
4/18/2015

Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies...

GW Cancer Institute publishes core competencies for oncology patient navigators
4/18/2015

The George Washington University (GW) Cancer Institute has finalized 45 core competency statements for oncology patient navigators, who have become critical members of the health care team.

Review provides further insight into link between hormone therapy and breast cancer
4/18/2015

A review of two clinical trials that are a part of the Women's Health Initiative delves further into the association between hormone therapy and the risk of breast cancer.

Smokers underestimate risks of a few cigarettes: Survey shows that many live in 'denial' of the real risks
4/17/2015

Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at...

Genetic variability may help predict tumor aggressiveness and treatment success
4/17/2015

A new method that measured genetic variability in tumor cells from patients with head and neck cancer found high scores correlated with lower patient survival.

Provectus Biopharmaceuticals opens patient enrollment and begins phase 3 international FDA comparative clinical trial of PV-10 for melanoma
4/17/2015

Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, enters phase 3 and has opened enrollment of patients for its phase 3 international FDA...

New liver cancer treatment approved for use in Europe
4/17/2015

A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety.

VETIGEL prepares to launch in U.K. veterinary market - new product stops bleeding in fewer than 10 seconds
4/17/2015

VetPlus, a leading nutraceutical manufacturer, has announced that it will be the sole U.K. distributor of a new product set to revolutionise the way veterinarians manage bleeding.